$1 Million in Funding Available to Drive Therapies for Duchenne Muscular Dystrophy
HAMILTON, N.J. and STATEN ISLAND, N.Y., Aug. 21, 2018 /PRNewswire-iReach/ -- Several gene therapies for Duchenne muscular dystrophy have...
Families of Boys with Duchenne Muscular Dystrophy Band Together to Fund Research
BALTIMORE, MD – (April 12, 2017) Three grassroots foundations founded by the families of young boys diagnosed with Duchenne muscular...
DMD Therapeutics Inc. Receives Funding from DMD Foundations to Develop DMD-813 for Treatment of Duch
SEATTLE, Feb. 24 2017 /PRNewswire/ -- DMD Therapeutics, Inc., a start-up biotech company, is developing proprietary therapeutics for...

Two Nonprofit Organizations Award Iowa State University $150,000 for Muscular Dystrophy Research
AMES, Iowa — Ryan’s Quest and Michael’s Cause, two nonprofit organizations, have provided a $150,000 grant to Iowa State University to...

Michael's Cause, Ryan's Quest, Save Our Sons, Pietro's Fight, and Foundation LaForce Pro
HAMILTON, N.J., March 24, 2016 /PRNewswire-iReach/ -- Ryan's Quest, a New Jersey based non-profit organization dedicated to finding...

The Jett Foundation, Michael’s Cause and Ryan’s Quest Donate $15,000 to Scientific Committee Reviewi
Dec.4, 2015 — Three Duchenne muscular dystrophy nonprofits have donated $5,000 each to TREAT-NMD Advisory Committee for Therapeutics...
Ryan’s Quest Clinical Trial Grant for Steroid Alternative
Hamilton, New Jersey, August 3, 2015—The Ryan’s Quest Foundation, a non-profit organization specific to Duchenne muscular dystrophy,...

NEWS: Akashi Therapeutics Reports Positive Clinical Data on HT-100 in Patients with Duchenne Muscula
Interim Clinical Data from Ongoing Phase 1b/2a Clinical Program Highlights Statistically Significant Improvements in Muscle Strength...
NEWS: First Duchenne Muscular Dystrophy Patient Treated in Follistatin Gene Therapy Trial
Cleveland and Columbus, OH, April 9, 2015—Milo Biotechnology announced the first Duchenne muscular dystrophy (DMD) patient was treated...